Table 4.

Galectin-3 and the hazard ratio of ischaemic stroke, stratified by median age

Model	N	Q1	Q2	Q3	Q4	P value overall
1. Age < 64
A	489	Referent	2.1 (1.1, 4.0), P = 0.03	3.0 (1.6, 5.8), P < 0.001	2.0 (1.0, 4.2), P = 0.06	0.008
B	489	Referent	2.7 (1.3, 5.4), P = 0.006	4.0 (1.9, 8.5), P < 0.001	2.4 (1.1, 5.3), P = 0.03	0.004
C	443	Referent	1.6 (0.8, 3.5), P = 0.19	2.7 (1.1, 6.3), P = 0.02	1.6 (0.7, 4.0), P = 0.30	0.16
D	443	Referent	1.6 (0.7, 3.5), P = 0.28	2.8 (1.1, 6.8), P = 0.03	1.7 (0.7, 4.6), P = 0.27	0.17
2. Age 64+
A	984	Referent	1.0 (0.6, 1.6), P = 0.87	1.0 (0.6, 1.7), P = 0.91	1.3 (0.8, 2.1), P = 0.29	0.49
B	984	Referent	0.8 (0.5, 1.3), P = 0.37	0.8 (0.5, 1.3), P = 0.37	1.0 (0.6, 1.5), P = 0.85	0.67
C	919	Referent	0.7 (0.4, 1.2), P = 0.22	0.9 (0.5, 1.4), P = 0.55	0.9 (0.5, 1.4), P = 0.56	0.67
D	919	Referent	0.7 (0.4, 1.2), P = 0.16	0.8 (0.5, 1.3), P = 0.38	0.8 (0.5, 1.4), P = 0.49	0.58

Models: A, unadjusted; B, adjusted for age, sex, race, age × race; C, model B + Framingham stroke risk factors (diabetes, systolic blood pressure, use of any antihypertensive medications, left ventricular hypertrophy, history of coronary artery disease, atrial fibrillation); D, model C + income, education. N, total number of participants in the analysis; Q, quartile.